Stojanoski Sinisa, Manevska Nevena, Antovic Svetozar, Pop-Gjorcheva Daniela, Vaskova Olivija, Miladinova Daniela, Mileva Magdalena
Institute for Pathophysiology, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
University Clinic for Digestive Surgery, Faculty of Medicine, Ss Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
Open Access Maced J Med Sci. 2017 Sep 15;5(6):744-750. doi: 10.3889/oamjms.2017.166. eCollection 2017 Oct 15.
Colorectal cancer (CRC) is the second commonest cancer in women, the third in men, being the fourth commonest cause of cancer death. The most important factor for prognosis and staging in CRC patients is the status of the regional lymph nodes (LN).
To implement the method for sentinel lymph node (SLN) detection in CRC patients using radiocolloid, and test its detection rate, sensitivity, accuracy, negative predictive value and the possibility for upstaging.
The study included 40 CRC patients, age 63 ± 14 years, without LNs detected on CT or MRI. SLN detection was performed after endoscopically peri- and intratumoral injection of 99mTc-SENTISCINT. All patients underwent resection with systemic lymphadenectomy, and the SLNs were detected ex vivo. Pathohistology was performed to all resected LNs.
The identification rate was 95%, the accuracy of the procedure was 92.1%, the negative predictive value was 86.95%, the sensitivity was 83.3%, and the upstage was 22.5%.
Identification of SLNs in CRC patients with this method is possible and the detection rate, negative predictive value, accuracy and sensitivity are reliable. We expect to contribute in the upstaging of stage II CRC patients and the selection of appropriate oncology treatment protocols.
结直肠癌(CRC)是女性第二常见的癌症,男性第三常见的癌症,是癌症死亡的第四大常见原因。CRC患者预后和分期的最重要因素是区域淋巴结(LN)的状态。
应用放射性胶体实施CRC患者前哨淋巴结(SLN)检测方法,并测试其检测率、敏感性、准确性、阴性预测值以及分期上调的可能性。
该研究纳入40例CRC患者,年龄63±14岁,CT或MRI未检测到LN。在内镜下肿瘤周围和肿瘤内注射99mTc-SENTISCINT后进行SLN检测。所有患者均接受手术切除并进行系统性淋巴结清扫,前哨淋巴结在体外检测。对所有切除的淋巴结进行病理组织学检查。
识别率为95%,该方法的准确性为92.1%,阴性预测值为86.95%,敏感性为83.3%,分期上调率为22.5%。
用该方法识别CRC患者的前哨淋巴结是可行的,检测率、阴性预测值、准确性和敏感性可靠。我们期望对II期CRC患者的分期上调及合适的肿瘤治疗方案的选择做出贡献。